MedPath

The effect of local fibrinogen administration on postoperative bleeding in CABG patients

Phase 3
Conditions
coronary artery bypass graft.
Atherosclerotic heart disease
Registration Number
IRCT201510222804N9
Lead Sponsor
Vice chancellor for research, Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
50
Inclusion Criteria

age between 40-75 years old; elective CABG with CPB; constant surgeon; informed written consent.
The following conditions were considered as exclusion criteria: emergent or urgent surgery; age more than 75 years or less than 40 years old; diabetes mellitus (or any of its complications like diabetic ketoacidosis or non-ketonic hyperosmolar diabetic coma); any previous history of stroke or underlying cerebral vascular disease; history of deep vein thrombosis; history of underlying hematologic disorders; any carotid plaque creating significant stenosis (stenosis > 75%); underlying pulmonary disorders affecting the spirometry indices significantly (>50% decrease); acute renal failure; chronic kidney disease causing serum Cr>2mg/dL; hepatic failure causing liver function test failure (> 3 times than normal); off pump CABG; any unwanted complication in the operation period; re-starting CPB after weaning from bypass; pulmonary artery pressure >30 before operation; ejection fraction<30%; congestive heart failure.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Postoperative bleeding. Timepoint: Early 24 hours in postoperative period. Method of measurement: Postoperative amount of blood loss in chest tube bottles.
Secondary Outcome Measures
NameTimeMethod
Hematocrit level. Timepoint: Early 24 hours hematocrit in postoperative period. Method of measurement: Preoperative and postoperative hematocrit level.
© Copyright 2025. All Rights Reserved by MedPath